# Stage 1 Prototype Completion & Stage 2 Transition Dossier

## 1. Prototype Milestone Verification
Stage 1 (Validated Case-Processing Prototype) is technically complete:
- [x] End-to-end report submission, Pydantic validation, and PostgreSQL persistence
- [x] Possible duplicate detection and case-linking
- [x] Structured AI information extraction with MedDRA normalization
- [x] OpenFDA & versioned drug label retrieval (RAG)
- [x] Deterministic safety triage rules (100% sensitivity on serious events)
- [x] Medical reviewer queue and clinical adjudication endpoint
- [x] Streamlit web application (Submission, Case Lookup, Reviewer Dashboard)
- [x] Immutable audit trail for every case update
- [x] 38 automated test cases passing across all components
- [x] Development benchmark report (`evaluation/reports/stage1_evaluation_report.md`)

---

## 2. Transition Plan to Stage 2 (Clinical Evaluation)

Before deploying or evaluating in real clinical or hospital workflows, Stage 2 mandates:

### A. Real-World & Expert Annotated Reference Cases
- Partner with clinical pharmacovigilance collaborators to obtain de-identified, expert-annotated adverse event cases.
- Synthetic cases were used for initial technical validation; real-world messy clinical narratives are required for Stage 2.

### B. Shadow-Mode Deployment
- Run the system in **read-only shadow mode** alongside hospital safety teams.
- Compare AI-recommended triage and extraction against senior human reviewers.
- Document and adjudicate any discrepancies.

### C. Clinical Metrics & Discrepancy Analysis
- Measure clinical false negatives, serious-event sensitivity at scale, and subgroup performance.
- Perform root-cause failure analysis for any unlisted reaction classifications.

> ⚠️ **Scope Boundary Notice:** Stage 1 establishes software technical readiness. Clinical validity and regulatory deployment are subject to Stage 2 and Stage 3 outcomes.
